PL1926472T3 - Stabilizowane i konserwowane kompozycje oftalmologiczne zawierające ketotifen - Google Patents
Stabilizowane i konserwowane kompozycje oftalmologiczne zawierające ketotifenInfo
- Publication number
- PL1926472T3 PL1926472T3 PL06802303T PL06802303T PL1926472T3 PL 1926472 T3 PL1926472 T3 PL 1926472T3 PL 06802303 T PL06802303 T PL 06802303T PL 06802303 T PL06802303 T PL 06802303T PL 1926472 T3 PL1926472 T3 PL 1926472T3
- Authority
- PL
- Poland
- Prior art keywords
- ophthalmic compositions
- stabilized
- hydrogen peroxide
- preserved
- ketotifen ophthalmic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/212,957 US20070048388A1 (en) | 2005-08-26 | 2005-08-26 | Stabilized and preserved ketotifen ophthalmic compositions |
PCT/US2006/033163 WO2007025094A2 (en) | 2005-08-26 | 2006-08-24 | Stabilized and preserved ketotifen ophthalmic compositions |
EP06802303A EP1926472B1 (en) | 2005-08-26 | 2006-08-24 | Stabilized and preserved ketotifen ophthalmic compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1926472T3 true PL1926472T3 (pl) | 2011-09-30 |
Family
ID=37670685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06802303T PL1926472T3 (pl) | 2005-08-26 | 2006-08-24 | Stabilizowane i konserwowane kompozycje oftalmologiczne zawierające ketotifen |
Country Status (19)
Country | Link |
---|---|
US (4) | US20070048388A1 (pl) |
EP (1) | EP1926472B1 (pl) |
JP (1) | JP5172678B2 (pl) |
KR (1) | KR20080042143A (pl) |
CN (1) | CN101252908B (pl) |
AT (1) | ATE505182T1 (pl) |
AU (2) | AU2006282980A1 (pl) |
BR (1) | BRPI0615384B8 (pl) |
CA (1) | CA2619834C (pl) |
CY (1) | CY1111678T1 (pl) |
DE (1) | DE602006021321D1 (pl) |
DK (1) | DK1926472T3 (pl) |
ES (1) | ES2363988T3 (pl) |
MX (1) | MX2008002653A (pl) |
PL (1) | PL1926472T3 (pl) |
PT (1) | PT1926472E (pl) |
RU (1) | RU2442583C2 (pl) |
SI (1) | SI1926472T1 (pl) |
WO (1) | WO2007025094A2 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070208058A1 (en) * | 2004-10-25 | 2007-09-06 | Bryant Roy W | Stable Pharmaceutical Compositions and Methods of Making and Using Same |
US20070048389A1 (en) * | 2005-08-26 | 2007-03-01 | Fu-Pao Tsao | Stabilized and preserved ketotifen ophthalmic compositions |
US20090220618A1 (en) * | 2008-02-29 | 2009-09-03 | Erning Xia | Pharmaceutical formulations comprising polyanionic materials and source of hydrogen peroxide |
WO2010107525A1 (en) * | 2009-03-17 | 2010-09-23 | Aciex Therapeutics, Inc. | Ophthalmic formulations of ketotifen and methods of use |
CN110024781A (zh) * | 2019-05-23 | 2019-07-19 | 昆明野水生物科技有限公司 | 一种在常温下能迅速杀灭芽孢的制剂及其应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4614646A (en) * | 1984-12-24 | 1986-09-30 | The Dow Chemical Company | Stabilization of peroxide systems in the presence of alkaline earth metal ions |
US4819617A (en) * | 1986-09-04 | 1989-04-11 | University Of Florida | Viscoelastic material for ophthalmic surgery |
ATE141803T1 (de) * | 1988-08-04 | 1996-09-15 | Ciba Geigy Ag | Verfahren zur konservierung ophthalmischer lösungen und zusammensetzungen dafür |
US5607698A (en) * | 1988-08-04 | 1997-03-04 | Ciba-Geigy Corporation | Method of preserving ophthalmic solution and compositions therefor |
US5019591A (en) * | 1989-02-17 | 1991-05-28 | Pennsylvania Research Corporation | Method for treating retinopathy and other small vessel disorders associated with diabetes |
EP0938896A1 (en) * | 1998-01-15 | 1999-09-01 | Novartis AG | Autoclavable pharmaceutical compositions containing a chelating agent |
WO2000019981A1 (en) * | 1998-10-08 | 2000-04-13 | Karagoezian Hampar L | Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide |
WO2002026277A2 (en) * | 2000-09-28 | 2002-04-04 | Novartis Ag | Stabilized hydrogen peroxide solutions |
US20070092582A1 (en) * | 2002-01-18 | 2007-04-26 | Fu-Pao Tsao | Methods of preserving ophthalmic solutions and preserved ophthalmic solutions |
JP2004143157A (ja) * | 2002-10-01 | 2004-05-20 | Taisho Pharmaceut Co Ltd | 点眼剤 |
US20050244509A1 (en) * | 2004-03-17 | 2005-11-03 | Fu-Pao Tsao | Ophthalmic solutions |
-
2005
- 2005-08-26 US US11/212,957 patent/US20070048388A1/en not_active Abandoned
-
2006
- 2006-08-24 CA CA2619834A patent/CA2619834C/en active Active
- 2006-08-24 KR KR1020087007222A patent/KR20080042143A/ko not_active Application Discontinuation
- 2006-08-24 PL PL06802303T patent/PL1926472T3/pl unknown
- 2006-08-24 MX MX2008002653A patent/MX2008002653A/es active IP Right Grant
- 2006-08-24 JP JP2008528166A patent/JP5172678B2/ja not_active Expired - Fee Related
- 2006-08-24 BR BRPI0615384A patent/BRPI0615384B8/pt active IP Right Grant
- 2006-08-24 AT AT06802303T patent/ATE505182T1/de active
- 2006-08-24 AU AU2006282980A patent/AU2006282980A1/en not_active Abandoned
- 2006-08-24 RU RU2008111067/15A patent/RU2442583C2/ru not_active IP Right Cessation
- 2006-08-24 PT PT06802303T patent/PT1926472E/pt unknown
- 2006-08-24 ES ES06802303T patent/ES2363988T3/es active Active
- 2006-08-24 CN CN200680031237XA patent/CN101252908B/zh not_active Expired - Fee Related
- 2006-08-24 WO PCT/US2006/033163 patent/WO2007025094A2/en active Application Filing
- 2006-08-24 SI SI200631024T patent/SI1926472T1/sl unknown
- 2006-08-24 DE DE602006021321T patent/DE602006021321D1/de active Active
- 2006-08-24 EP EP06802303A patent/EP1926472B1/en active Active
- 2006-08-24 DK DK06802303.5T patent/DK1926472T3/da active
-
2008
- 2008-04-15 US US12/082,844 patent/US20080193558A1/en not_active Abandoned
-
2010
- 2010-11-03 AU AU2010241211A patent/AU2010241211B2/en not_active Ceased
-
2011
- 2011-06-28 CY CY20111100610T patent/CY1111678T1/el unknown
- 2011-12-20 US US13/330,992 patent/US20120095050A1/en not_active Abandoned
-
2012
- 2012-11-09 US US13/673,050 patent/US20130102634A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2363988T3 (es) | 2011-08-22 |
CA2619834C (en) | 2014-05-06 |
AU2010241211A1 (en) | 2010-11-25 |
CA2619834A1 (en) | 2007-03-01 |
ATE505182T1 (de) | 2011-04-15 |
BRPI0615384A2 (pt) | 2011-05-17 |
CN101252908A (zh) | 2008-08-27 |
EP1926472B1 (en) | 2011-04-13 |
US20080193558A1 (en) | 2008-08-14 |
WO2007025094A3 (en) | 2007-05-18 |
US20120095050A1 (en) | 2012-04-19 |
DK1926472T3 (da) | 2011-07-18 |
RU2008111067A (ru) | 2009-10-10 |
SI1926472T1 (sl) | 2011-07-29 |
CN101252908B (zh) | 2011-09-14 |
WO2007025094A2 (en) | 2007-03-01 |
US20070048388A1 (en) | 2007-03-01 |
CY1111678T1 (el) | 2015-10-07 |
JP2009506065A (ja) | 2009-02-12 |
US20130102634A1 (en) | 2013-04-25 |
BRPI0615384B8 (pt) | 2021-05-25 |
MX2008002653A (es) | 2008-03-18 |
PT1926472E (pt) | 2011-07-11 |
KR20080042143A (ko) | 2008-05-14 |
DE602006021321D1 (de) | 2011-05-26 |
EP1926472A2 (en) | 2008-06-04 |
JP5172678B2 (ja) | 2013-03-27 |
AU2010241211B2 (en) | 2012-12-20 |
AU2006282980A1 (en) | 2007-03-01 |
RU2442583C2 (ru) | 2012-02-20 |
BRPI0615384B1 (pt) | 2019-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1984357E (pt) | Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes | |
MX2009005455A (es) | (r)-n-estereoisomeros de analogos de 7,8-saturados-4,5 epoxi-morfinano. | |
MY142777A (en) | Substituted indole-o-glucosides | |
MX2009000285A (es) | Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas. | |
MX2009003821A (es) | Compuestos de n-aril pirazol para usarse contra la diabetes. | |
GEP20135724B (en) | Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for treatment or prevention of diabetes | |
UA87991C2 (en) | Substituted indole-o-glucosides | |
IL195256A0 (en) | Compositions of r(+)and s(-)pramipexole and methods of using the same | |
EP1765335A4 (en) | PYRAZOLAMIDE DERIVATIVES, COMPOSITIONS AND METHODS OF APPLYING THESE COMPOUNDS | |
TW200745037A (en) | Organic compounds | |
MY143599A (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
HK1151966A1 (en) | Composition for proteasome inhibition | |
TW200745044A (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
EA201170703A1 (ru) | Производные адамантилбензамида | |
MX2007011695A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
MX2009005460A (es) | (s)-n-estereoisomeros de analogos de 7,8-saturados-4,5-epoxi-morfi nano. | |
TNSN07240A1 (en) | Compounds for flaviviridae treatment | |
TW200738143A (en) | Use of arylanilides for seed treatment | |
CY1111678T1 (el) | Σταθεροποιημενες και διατηρημενες οφθαλμικες ενωσεις κετοτιφενης | |
TW200720273A (en) | Pharmaceutically active spiro-benzimidazoles | |
DE602004018811D1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
EP2343048A3 (en) | Stabilized and preserved ketotifen ophthalmic compositions | |
MX2007013449A (es) | Composicion cosmetica para despigmentacion o aclaracion que comprende al menos una oxazolina como un ingrediente activo. | |
TW200815363A (en) | KV1.5 potassium channel inhibitors | |
UA3515U (uk) | Застосування перекису водню для профілактики сапролегніозу ікри риб |